Nuijen B, Bouma M, Manada C, Jimeno J M, Schellens J H, Bult A, Beijnen J H
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam.
Anticancer Drugs. 2000 Nov;11(10):793-811. doi: 10.1097/00001813-200011000-00003.
The marine ecosystem is more and more acknowledged as a source of potential anticancer agents. After the identification of a potential substance several hurdles have to be overcome before a marine candidate can enter the clinic. Amongst these are the establishment of a method which ensures sufficient supply and, which is the focus of this review, the development of a clinically useful pharmaceutical formulation. General issues with respect to the pharmaceutical development of marine anticancer agents will be discussed, which will be illustrated by highlighting aspects of the pharmaceutical development and clinical use of some representative compounds.
海洋生态系统越来越被认为是潜在抗癌药物的来源。在确定一种潜在物质后,一种海洋候选药物进入临床前必须克服几个障碍。其中包括建立一种确保充足供应的方法,而这也是本综述的重点,即开发一种临床上有用的药物制剂。将讨论海洋抗癌药物药物开发方面的一般问题,并通过强调一些代表性化合物的药物开发和临床应用方面加以说明。